Keyphrases
Antibiotic Treatment
100%
Sulfadoxine-pyrimethamine
100%
Child Growth
100%
Child Neurodevelopment
100%
DOK7
100%
Variable Severity
100%
Congenital Myasthenia
100%
Founder Variant
100%
Homozygosity
100%
Congenital Myasthenic Syndrome
75%
Pediatric Patients
75%
Azithromycin
66%
Facial Weakness
50%
Adult Patients
50%
Ptosis
50%
Pregnant Women
33%
Cumulative Incidence
33%
Inspiratory Stridor
25%
Ophthalmoparesis
25%
Ophthalmoplegia
25%
Limb-girdle
25%
Clinical Investigation
25%
Electrophysiological Study
25%
Correct Diagnosis
25%
Compound Heterozygous mutation
25%
Disease Severity
25%
Genetic Investigation
25%
Feeding Difficulties
25%
Wheelchair
25%
Respiratory Insufficiency
25%
Early Diagnosis
25%
Ventilator
25%
At Birth
25%
Molecular Genetics
25%
Intermittent Preventive Treatment
22%
Height-for-age Z-score
22%
Cognitive Performance
22%
During Pregnancy
11%
Between-group
11%
Anthropometric Measurements
11%
Mean Height
11%
Malaria Endemic Areas
11%
Intergroup Difference
11%
Raven's Colored Progressive Matrices
11%
Coloured Progressive Matrices
11%
Mangochi
11%
Southern Malawi
11%
Body Mass Index
11%
Linear Developments
11%
Mid-upper Arm Circumference
11%
Medicine and Dentistry
Sulfadoxine/Pyrimethamine
100%
Child Growth
100%
Antibiotic Therapy
100%
Nerve Cell Differentiation
100%
Congenital Myasthenic Syndrome
100%
Homozygosity
100%
Pediatrics Patient
75%
Azithromycin
66%
Ophthalmoparesis
50%
Facial Weakness
50%
Ptosis
50%
Cumulative Incidence
33%
Offspring
33%
Stridor
25%
Early Diagnosis
25%
Disease Severity
25%
Limb
25%
Respiratory Failure
25%
Prevalence
22%
Prophylaxis
22%
Growth, Development and Aging
11%
Arm
11%
Anthropometry
11%
Body Mass Index
11%
Infection Control
11%
Nursing and Health Professions
Pyrimethamine Plus Sulfadoxine
100%
Antibiotic Therapy
100%
Azithromycin
66%
Child
33%
Prophylaxis
22%
Prevalence
22%
Head Circumference
11%
Infection Control
11%
Arm Circumference
11%
Body Mass
11%
Anthropometry
11%